You are here

Article info

Article menu

Download PDFPDF

Section 4: Clinical Pharmacy Services
4CPS-156 Analysis of the effectiveness and safety of daratumumab in monotherapy in adult patients with relapsed refractory multiple myeloma
Free

Authors

Citation

Alarcon-Payer C, López López A, Gómez-De Rueda F, et al
4CPS-156 Analysis of the effectiveness and safety of daratumumab in monotherapy in adult patients with relapsed refractory multiple myeloma
European Journal of Hospital Pharmacy 2020;27:A121.

Publication history

  • First published March 24, 2020.
Online issue publication 
August 05, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.